Literature DB >> 29380903

Iron as a therapeutic target for Parkinson's disease.

Caroline Moreau1, James A Duce2, Olivier Rascol3, Jean-Christophe Devedjian4, Daniela Berg5, David Dexter6, Z Ioav Cabantchik7, Ashley I Bush8, David Devos9.   

Abstract

Entities:  

Keywords:  Parkinson's disease; conservative iron chelation; dopamine oxidative stress; ferroptosis; α-synuclein

Mesh：

Substances：

Year:  2018        PMID： 29380903     DOI： 10.1002/mds.27275

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  39 in total

1.  Targeting Iron Dyshomeostasis for Treatment of Neurodegenerative Disorders.

Authors:  Niels Bergsland; Eleonora Tavazzi; Ferdinand Schweser; Dejan Jakimovski; Jesper Hagemeier; Michael G Dwyer; Robert Zivadinov
Journal:  CNS Drugs       Date:  2019-11       Impact factor: 5.749

2.  Iron and manganese-related CNS toxicity: mechanisms, diagnosis and treatment.

Authors:  Pan Chen; Melissa Totten; Ziyan Zhang; Hana Bucinca; Keith Erikson; Abel Santamaría; Aaron B Bowman; Michael Aschner
Journal:  Expert Rev Neurother       Date:  2019-02-21       Impact factor: 4.618

Review 3.  Ferroptosis and Brain Injury.

Authors:  Leslie Magtanong; Scott J Dixon
Journal:  Dev Neurosci       Date:  2019-02-28       Impact factor: 2.984

Review 4.  Gauging the role and impact of drug interactions and repurposing in neurodegenerative disorders.

Authors:  Dharmendra Kumar Khatri; Amey Kadbhane; Monica Patel; Shweta Nene; Srividya Atmakuri; Saurabh Srivastava; Shashi Bala Singh
Journal:  Curr Res Pharmacol Drug Discov       Date:  2021-04-08

5.  Overdosing on iron: Elevated iron and degenerative brain disorders.

Authors:  Santosh R D'Mello; Mark C Kindy
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-02

6.  Axonal Iron Transport might Contribute to Iron Deposition in Parkinson's Disease.

Authors:  Leilei Chen; Chong Li; Junxia Xie
Journal:  Neurosci Bull       Date:  2020-09-22       Impact factor: 5.203

Review 7.  Current Concepts and Controversies in the Management of REM Sleep Behavior Disorder.

Authors:  E Matar; S J McCarter; E K St Louis; S J G Lewis
Journal:  Neurotherapeutics       Date:  2021-01-06       Impact factor: 7.620

8.  Desferrioxamine Ameliorates Lipopolysaccharide-Induced Lipocalin-2 Upregulation via Autophagy Activation in Primary Astrocytes.

Authors:  Juntao Cui; Yu Yuan; Jun Wang; Ning Song; Junxia Xie
Journal:  Mol Neurobiol       Date:  2022-01-18       Impact factor: 5.590

9.  FTH1 Inhibits Ferroptosis Through Ferritinophagy in the 6-OHDA Model of Parkinson's Disease.

Authors:  Ye Tian; Juan Lu; Xiaoqian Hao; Hang Li; Guiyu Zhang; Xuelei Liu; Xinrong Li; Caiping Zhao; Weihong Kuang; Dongfeng Chen; Meiling Zhu
Journal:  Neurotherapeutics       Date:  2020-09-21       Impact factor: 7.620

Review 10.  Approaches to Disease Modification for Parkinson's Disease: Clinical Trials and Lessons Learned.

Authors:  Albert Y Hung; Michael A Schwarzschild
Journal:  Neurotherapeutics       Date:  2020-11-17       Impact factor: 7.620
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.